The Health Care M&A Monthly: Chiron Buys Vaccine Producer PowderJect for $878 Million
For the third time this year, our deal of the month involves a transaction in the Biotech sector. California’s Chiron Corp. (NASDAQ: CHIR) has agreed to buy Britain’s PowderJect Pharmaceuticals (LSE: PJP) for £542 million, or approximately $878 million. This purchase,...The Health Care M&A Monthly: Health Care M&A Results, First Quarter of 2003
Based on preliminary figures, a total of 218 mergers and acquisitions were announced in 13 sectors of the health care industry in the first quarter of 2003. This represents a nearly one-quarter (24%) drop in activity from the previous quarter, but a 3% gain from the...The Health Care M&A Monthly: The Envelope, Please: It’s Biotech, Again
For the second month straight, activity in the Biotechnology sector led the health care M&A market. In a slow month which saw a total of only 53 deals announced, the Biotech sector accounted for nine deals, or 17% of the total. Based on prices revealed to date,...The Health Care M&A Monthly:Johnson & Johnson to Buy Biotech Firm Scios For $2.7 Billion
Our choice for Deal of the Month carries the largest price tag for February, and reflects a recent surge of interest in the Biotechnology sector. It is the largest deal this sector has seen since Amgen (NASDAQ: AMGN) acquired Immunex for $11.1 billion last year. After...The Health Care M&A Monthly: Back in Business? M&A Activity Surges at Year’s End
The fourth quarter capped 2002 with a surge of M&A activity not seen in four years. A total of 286 transactions were announced in 13 sectors of the health care industry. Although some of this volume may come from dealmakers’ desire to close deals and improve...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
